Evidence map›Paper›PMID 31687520›Full record

ArticleHeliyon2019

Significance of transient receptor potential vanilloid 4 and aquaporin 5 co-expression in the rat uterus at term.

Eszter Ducza, Adrienn Csányi, Éva Szőke, Krisztina Pohóczky, Judit Hajagos-Tóth, Anna Kothencz, Zita Tiszai, Róbert Gáspár

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Physiological Cooperation between Aquaporin 5 and TRPV4.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Uterine contractions in rodent models and humans.Acta physiologica (Oxford, England) · 2021
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eszter DuczaDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Hungary.
Adrienn CsányiDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Hungary.
Éva SzőkeDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, Pécs, Hungary.
Krisztina PohóczkyDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, Pécs, Hungary.
Judit Hajagos-TóthDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Hungary.
Anna KothenczDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Hungary.
Zita TiszaiDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Hungary.
Róbert GáspárDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Hungary.
University of Szeged · HUUniversity of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAquaporins (AQPs) are channel proteins that facilitate the rapid passive movement of water. In our studies it was proved that the decreased AQP5 expression is followed by the increase of uterine contractility. The transient receptor potential vanilloid 4 (TRPV4) is a calcium channel, which is activated in response to osmotic changes. Our aim was to determine the possible role of AQP5 in this osmotic regulation of TRPV4, thus in pregnant uterine contraction. MAIN

methodsWe used RT-PCR and Western blot techniques for the detection of the TRPV4 expression during pregnancy in rat uterus. The localization of AQP5 and TRPV4 was determined by immunohistochemical studies. The role of TRPV4 in uterus contraction was investigated in an isolated organ bath system. KEY

findingsThe TRPV4 expression continuously increased from day 18 to the last day of pregnancy. The co-expression of TRPV4 and AQP5 in the myometrium and endometrium was determined in the late pregnant uterus. The TRPV4 antagonist and agonist significantly decreased and increased uterine contraction, respectively, especially on the last day of pregnancy. SIGNIFICANCE: We presume the decreased AQP5 expression triggers hypertonic stress, which activates TRPV4 and increases uterus contraction on the day of labor. Based on these findings, we suppose the TRPV4 effect on uterus contraction is AQP5 control, which could be a new target in preterm birth therapy.

Indexed as

AQP5Molecular biologyObstetricsPharmacologyPhysiologyPregnancyPreterm birthReproductive systemTRPV4

Identifiers

PMID31687520
PMCPMC6820280
OpenAlexW2981514692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.